The purpose of this study was to determine the effect of rendering newborn male Sprague-Dawley rats hypothyroid with 131I on development of the hypothalamic-pituitary axis. Hormonal responses to thyrotropin-releasing hormone (TRH). haloperidol (H), and luteinizing hormone-releasing hormone (LHRH) were determined at 9, 15, 30 and 75 days of age in hypothyroids and controls. Basal and TRH-stimulated thyroid-stimulating hormone (TSH) levels were higher in the hypothyroids, but the developmental patterns of basal TSH secretion and TSH reserve were parallel in the two groups, with maximal TSH secretion occurring at 30 days. Basal prolactin (PRL) and PRL responses to TRH and H were less in the hypothyroids at all ages. Basal LH and LH responses to LHRH were greater in the controls at days 9 and 15, but the hypothyroid rats displayed greater basal and stimulated LH secretion at 30 days and values similar to controls at 75 days of age. These results suggest that development of the hypothalamic-pituitary axis is altered in rats rendered hypothyroid shortly after birth.

Keywords:
Hypothyroidism, Maturation, Hypothalamic pituitary axis
This content is only available via PDF.
© 1980 S. Karger AG, Basel
1980
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.